Boehringer Ingelheim is seeking a Principal Scientist to join the DMPK group at our Ridgefield, CT headquarters. The role centers on developing cell-based and competitive ligand binding assays to evaluate neutralization activity of anti-drug antibodies in clinical samples for immunogenicity assessments.
You will lead assay development efforts, oversee CRO collaborations, and mentor junior scientists while ensuring compliance with GLP/GCP and regulatory expectations.
#J-18808-LjbffrPrincipal Scientist, Immunogenicity & nAb Assay Development in ridgefield at Unknown Company
This position is listed as full time and onsite.